MLchartDataset catalogue

survivin antigen

Term · Oncology and biomedicine · MLC-T-ONC-016920

A tumor-associated antigen. Vaccination with survivin antigen may result in a cytotoxic T-cell response against survivin antigen-expressing tumor cells, resulting in decreased tumor cell proliferation and tumor cell death. Overexpressed in many tumors, endogenous survivin inhibits tumor cell apoptosis.

Table 1. Record
IdentifierMLC-T-ONC-016920
FieldOncology and biomedicine
AbbreviationSRV
Synonymssurvivin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016920",
  "term": "survivin antigen",
  "field": "Oncology and biomedicine",
  "definition": "A tumor-associated antigen. Vaccination with survivin antigen may result in a cytotoxic T-cell response against survivin antigen-expressing tumor cells, resulting in decreased tumor cell proliferation and tumor cell death. Overexpressed in many tumors, endogenous survivin inhibits tumor cell apoptosis.",
  "abbreviation": "SRV",
  "synonyms": [
    "survivin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/survivin-antigen/"
}

Record 15,831 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.